<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The Institute of Medicine (IOM) proposed that <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors and their primary care providers (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e>) should receive survivorship care plans to inform ongoing care </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to determine <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e>' preferences for the content of survivorship care plans for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) survivors </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> in 3 practice-based research networks completed a survey regarding 45 topics of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> information based on the IOM's survivorship care plan framework </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: One hundred fifty-six <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> completed the survey </plain></SENT>
<SENT sid="4" pm="."><plain>For 35 topics (78%), at least half of respondents felt the topic was very important </plain></SENT>
<SENT sid="5" pm="."><plain>Most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> reported receiving too little information about problems with chemotherapy (68%) or radiation (60%) and whether the oncologist intended to monitor for other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (71%) </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> widely agreed that they do not have enough information about increased risk of second <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, and other diseases (78%); long-term effects of chemotherapy (73%) and radiation (67%); and genetic counseling (83%) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> endorse the IOM's survivorship care plan framework as relevant and often report needing more information </plain></SENT>
<SENT sid="8" pm="."><plain>Survivorship care plans may provide important information to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> by communicating patients' <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> histories and making recommendations regarding which aspects of care should be provided by the oncologist or the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> </plain></SENT>
</text></document>